Clinical trial
MERONEM: Observational Study About Efficacy of Meropenem in Comparison of Meropenem and Glycopeptide in Treatment of Neutropenia Febrile in Allogenic Blood Stem Cell Transplantation Patients
NCT00462878 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MERONEM: Observational Study About Efficacy of Meropenem in Comparison of Meropenem and Glycopeptide in Treatment of Neutropenia Febrile in Allogenic Blood Stem Cell Transplantation Patients
- Lead sponsor
- PETHEMA Foundation
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2002
- Completion date
- April 30, 2009
- Enrollment
- 392 (estimated)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.
allogenic blood stem cell transplantation, febrile neutropenia